LUMIADE 3: Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis
LUMIADE 3:地诺单抗生物类似药 FKS518 与参考产品在绝经后骨质疏松症中的治疗等效性
期刊:Journal of the Endocrine Society
影响因子:3.1
doi:10.1210/jendso/bvaf164
Krecipro-Nizinska, Ewa; Pluskiewicz, Wojciech; Supronik, Jerzy; Szeles, Peter; Petit-Frere, Corinne; Varone, Elsa; Ferrari, Serge; Valter, Ivo